Human immunodeficiency virus vectors for inducible expression of foreign genes.
about
Construction and molecular analysis of gene transfer systems derived from bovine immunodeficiency virusStructural determinants and mechanism of HIV-1 genome packagingComparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virusEfficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidationPosition dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivoRole of the DIS hairpin in replication of human immunodeficiency virus type 1The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structuresThe bovine leukemia virus encapsidation signal is discontinuous and extends into the 5' end of the gag geneA third-generation lentivirus vector with a conditional packaging systemLower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptaseInfectious molecular clones with the nonhomologous dimer initiation sequences found in different subtypes of human immunodeficiency virus type 1 can recombine and initiate a spreading infection in vitro.A packaging cell line for lentivirus vectors.The bovine leukemia virus encapsidation signal is composed of RNA secondary structures.High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.Separable mechanisms of attachment and cell uptake during retrovirus infection.Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34(+) cellsAn Mpsi-containing heterologous RNA, but not env mRNA, is efficiently packaged into avian retroviral particles.The inside out of lentiviral vectorsMapping the RNA binding sites for human immunodeficiency virus type-1 gag and NC proteins within the complete HIV-1 and -2 untranslated leader regions.Effects of second-site mutations on dominant interference by a human immunodeficiency virus type 1 envelope glycoprotein mutant.RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1.Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein.Selective infection of human T-lymphotropic virus type 1 (HTLV-1)-infected cells by chimeric human immunodeficiency viruses containing HTLV-1 tax response elements in the long terminal repeat.Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virusInducible human immunodeficiency virus type 1 packaging cell linesA conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replicationTruncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cellsMutations in the kissing-loop hairpin of human immunodeficiency virus type 1 reduce viral infectivity as well as genomic RNA packaging and dimerization.Beyond plasma membrane targeting: role of the MA domain of Gag in retroviral genome encapsidation.Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line.Transduction of human immunodeficiency virus type 1 vectors lacking encapsidation and dimerization signals.Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes.Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particlesPackaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region.Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays.Exploring Ty1 retrotransposon RNA structure within virus-like particlesTransduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles.Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.Development of HIV vectors for anti-HIV gene therapy.
P2860
Q24529091-8381427D-A9E5-427D-BA03-175229D7FC2AQ24632055-74A5131B-817C-4C38-80C2-402AF5935173Q24646050-8014DCF2-FF42-41AC-A828-E59B5D07A5C3Q24673792-4AAE84FD-0CCD-44B6-BA7D-5AE0D80E27ECQ24678656-60FB69F4-D174-455B-8F55-CA50491BB690Q24680551-AA4C16EF-4CFA-4F19-90C3-922F97C389FEQ24682817-78CBDE6E-B8C1-4AA7-9553-E4F0E814580AQ28301200-7EC879EB-AED6-439A-9709-B6DF46DEC74FQ29616120-C4C68A5F-696C-4760-B29A-3000D6542124Q29619994-F6D25198-1FA5-45FD-8DD5-C8D018D8941FQ30430249-FCC22A30-A187-484E-A5A3-BA6298DECE47Q33639623-09501B6F-0D4B-4BCD-9623-77A648DCF2C4Q33783331-E6709C8C-1564-4A4D-9EE6-9B6097555383Q33785302-FB28EFE6-5CCA-4868-BE47-73FC5D1764ABQ33787363-8C7503C5-1402-4A08-8ABE-25DC17F10D1FQ33793274-93087E70-4143-4CBD-9643-FDF41BAFE523Q33822142-A6516502-CCD3-4E67-B56B-D7B11E32B198Q34633466-25C37B22-145B-4CBD-B7A8-8B01E697503AQ34673247-FDCF7153-277A-4DED-9AE4-6EC2599B9A5AQ35833507-325773E0-8A27-4703-8EDC-7FDD5E8A3EBAQ35837228-EA372798-3A67-4ADB-9374-477232E63D09Q35839778-2399F21D-AADE-42EB-9B62-E16980D0A98FQ35851228-9DFC590D-5876-4B6C-9CF7-D358BEC8BFA3Q35861853-13963211-F5E4-4216-AFDB-29491BC93345Q35864277-6596C6E8-FAB7-42C3-8F38-8491B18FD98BQ35879394-889B501E-FB4D-436F-9530-29286744B3DDQ35882018-E45D7A13-D2B9-4A70-BCD6-7F2C74E0A0C7Q35882188-43E100F3-F1F3-4482-A69C-FA679B32D8C6Q35893976-4ED513D4-D52F-4255-BAD9-8585A85F981AQ35943050-84625CDA-9B7B-452D-9217-6DA0B83043D1Q36099054-016BF33C-CA6C-4A55-AF4F-3E1245AA640BQ36634241-F238FFB3-7095-42C9-B21C-938EEF0F8408Q36634329-BF7F7EB9-E07A-454A-AFF2-2B67A88FAE02Q36645412-8E4B3431-984D-443D-85AB-1684C449AE2EQ36649979-F617F355-591D-4C37-AE4F-C5D6769CD6C8Q36655093-5DF1B28A-FE51-42B4-8726-C4BEB3C0D906Q36668768-9CE7E845-80CD-4892-8613-390A70EFA050Q37090592-E9FBB171-6CA2-4FC9-8806-B8DAEE6AF0E8Q37251114-D66F2EB9-17B2-4DB4-B193-C7B929916C70Q37251477-B6E02FA0-C1A5-45DC-B8DB-35F78DA3D774
P2860
Human immunodeficiency virus vectors for inducible expression of foreign genes.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Human immunodeficiency virus vectors for inducible expression of foreign genes.
@en
type
label
Human immunodeficiency virus vectors for inducible expression of foreign genes.
@en
prefLabel
Human immunodeficiency virus vectors for inducible expression of foreign genes.
@en
P2860
P1433
P1476
Human immunodeficiency virus vectors for inducible expression of foreign genes.
@en
P2093
A T Panganiban
G L Buchschacher
P2860
P304
P407
P577
1992-05-01T00:00:00Z